Loading chat...
MA H1274
Bill
Status
Introduced
2/27/2025
Primary Sponsor
Brian Murray
Click for details
AI Summary
- Pharmacy benefit managers (PBMs) are prohibited from reimbursing 340B covered entities at lower rates than non-340B entities for the same drugs
- PBMs cannot assess fees, charge-backs, or other adjustments on entities solely because they participate in the federal 340B drug discount program
- Network restrictions based on 340B status are banned, including requiring 340B entities to contract with specific pharmacies to join PBM networks
- PBMs cannot require claims to include 340B drug identifiers or modifiers unless the claim involves Medicaid payment
- Patients cannot be charged higher copays, coinsurance, or additional fees for obtaining drugs from 340B entities, and PBMs cannot steer patients away from 340B pharmacies through incentives or inducements
Legislative Description
Prohibiting PBMs from discriminating against hospitals and patients participating in the 340B drug discount program
Last Action
Accompanied a new draft, see H4494
9/18/2025
Committee Referrals
Financial Services2/27/2025
Full Bill Text
No bill text available